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Summary
Wiskott–Aldrich syndrome (WAS) and X-linked neutropenia (XLN) are immunodeficiencies in which the function of several
haematopoietic cell lineages is perturbed as a result of mutations in the actin regulator WASp. From in vitro cell biology experiments, and
biochemical and structural approaches, we know much about the functional domains of WASp and how WASp might regulate the dynamic
actin cytoskeleton downstream of activators such as Cdc42, but in vivo experiments are much more challenging. In patients, there is a
correlation between clinical disease and genotype, with severe reductions in WASp expression or function associating with complex
multilineage immunodeficiency, whereas specific mutations that cause constitutive activation of WASp result in congenital neutropenia.
Here, we take advantage of the genetic tractability and translucency of zebrafish larvae to first characterise how a null mutant in zfWASp
influences the behaviour of neutrophils and macrophages in response to tissue damage and to clearance of infections. We then use this
mutant background to study how leukocyte lineage-specific transgenic replacement with human WASp variants (including normal wild type
and point mutations that either fail to bind Cdc42 or cannot be phosphorylated, and a constitutively active mutant equivalent to that seen in
XLN patients) alter the capacity for generation of neutrophils, their chemotactic response to wounds and the phagocytic clearance capacity
of macrophages. This model provides a unique insight into WASp-related immunodeficiency at both a cellular and whole organism level.
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Introduction
Cells of the innate immune system depend on a precisely
regulated actin cytoskeleton to drive a coordinated response to
tissue damage and infection and to clear pathogens at sites of
infection. From cell surface receptor through to actin nucleator,
each component step in cytoskeletal regulation plays a pivotal
role in enabling normal immune cell function.
Wiskott–Aldrich syndrome (WAS) protein WASp coordinates
actin polymerisation via the Arp2/3 complex downstream of
Cdc42 and kinase phosphorylation. Innate immune cells deficient
in WASp, including neutrophils and macrophages, have been
shown to display abnormal chemotaxis, motility and phagocytosis
in vitro (Thrasher and Burns, 2010; Tsuboi and Meerloo, 2007).
For example, tissue culture studies reveal that WASp-deficient
macrophages fail to respond to chemotactic cues due to reduced
persistence of directed protrusions (Ishihara et al., 2012; Zicha
et al., 1998). They are also defective at phagocytosis of bacteria
and apoptotic cells (Leverrier et al., 2001; Lorenzi et al., 2000).
Several studies indicate a correlation between the clinical
phenotype of WAS and the nature of the inherited mutation (Jin
et al., 2004), with truncated or abolished WASp expression
coinciding with the most severe cases (Ochs and Thrasher, 2006).
In contrast, X-linked Neutropenia (XLN) in patients, results from
constitutively active mutations in WASp, and presents with
congenital neutropenia (Ancliff et al., 2006; Devriendt et al., 2001).
In recent years zebrafish, Danio rerio, has come to the fore as a
model for live imaging innate immune cell ontogeny,
developmental homing and response to tissue damage, infection
and cancer (Deng et al., 2012; Feng et al., 2010; Le Guyader et al.,
2008; Levraud et al., 2009; Mathias et al., 2006; Niethammer
et al., 2009; Prajsnar et al., 2008; Renshaw et al., 2006).
We have shown that the WASp protein is conserved in zebrafish
and using a morpholino knockdown approach we previously
reported that WASp deficient neutrophils and macrophages exhibit
defects in their capacity to migrate towards a fin wound, suggesting
that WASp function is conserved in fish (Cvejic et al., 2008). In this
study we characterise a null mutant of zebrafish WASp, which
shows defects in both the wound-induced inflammatory response
and in immune-cell-mediated resistance to bacterial infection, thus
mimicking the symptoms of human WAS patients. We then use
transgenic replacement with a range of human WASp mutants using
the Gal4:UAS system in order to observe how various human
mutations affect innate immune cell behaviour in vivo.
This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution
and reproduction in any medium provided that the original work is properly attributed.
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Fig. 1. The Zebrafish WASp mutant has a defect in leukocyte wound recruitment. (A) Schematic of WASp protein domains with the site of the STOP codon
in washu3280 mutant indicated (red). (B) Schematic of 3 dpf zebrafish larva showing haematopoietic cell location (green) and wound (red arrow). (C) Time course
of Sudan-Black-positive neutrophil recruitment in WT versus mutant larvae (i). Two-way ANOVA, Bonferroni post-test at each time-point 0.5 hour (NS),
1 hour (***), 1.5 hours (***), 2 hours (***), 2.5 hours (**), 3 hours (***), 4 hours (**), 5 hours (***), 6 hours (NS). Representative images of Sudan-Black-
stained neutrophils recruited to the 90 minute wound site (ii) in WT (a) and mutant (b). (D) Time-course of macrophage recruitment in WT versus mutant
mpx:GFP+ larvae (i). Two-way ANOVA, Bonferroni post-test at each time point 1 hour (NS), 2 hours (*), 3 hours (**), 5 hours (***), 7 hours (***), 9 hours
(***), 24 hours (NS). Representative images of 3 hour wounds immunostained for L-Plastin to reveal all leukocytes (red) and mpx:GFP+ neutrophils (green) at the
wound site (ii) in WT (a) and mutant (b). (E) Representative tracking analysis of mpx:GFP+ neutrophils during the first 90 minutes post
wounding of a WT larva (i); each neutrophil track is in a different colour and the wound is indicated by dotted lines. Graphic representation of the velocity of
migrating cells (mm/second) (ii), pause duration (seconds) with number of pauses.1 minute during wound migration (in brackets) (iii) and cell meandering index
(iv), taken from tracks of WT (n520) and mutant (n520) mpx:GFP+ neutrophils. (F–H) Sample still images from confocal movies to illustrate protrusion/
retraction analysis (i); neutrophils are green and new protrusive areas are indicated in magenta (F,G); and the retracting uropod in blue (H). WT cells exhibit
greater persistence of polarity towards the wound (red asterisk). (F) (ii) Comparison of protrusive area (front versus back ratio analysis) in paused cells of WT vs
mutant larvae. (G) (ii) As in F, but for migrating WT versus mutant cells, showing reduced protrusion in mutant cells. (H) (ii) Retraction analysis applied to
migrating WT versus mutant cells, revealing mutant has defect in rate of uropod retraction. Error bars: s.e.m. (C,D); s.d. (E–H); *P,0.05; **P,0.01;
***P,0.001 by one-way ANOVA (C,D) and Student’s t-test (E–H). NS, not significant. Scale bars: 10 mm (C,D); 20 mm (E); 5 mm (F–H).
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Fig. 2. The Zebrafish WASp mutant can be rescued to varying degrees by introduction of WT hWASp and clinical WASp mutants. (A) Schematic
of hWASp indicating the various mutant constructs for attempted rescue of the zebrafish mutant phenotype. (B) (i) lyz:Gal4-VP16 UAS:Kaede to reveal
neutrophils (green), shows evidence of neutropenia only in the flanks of -/hWASpI294T ‘rescued larvae’ with (ii) quantification of neutrophil deficiency by
measurement of total neutrophil area in the hematopoietic region. (C) Degree of ‘rescue’ of neutrophil recruitment at 2 hours post wounding, after expression of
hWASp constructs in the mutant background. (D) Tracking analysis of neutrophils following expression of each of the hWASp mutant constructs:
(i) Quantification of the velocity of migrating cells (mm/sec), and (ii) pause duration (seconds), and pause number (in brackets). (E) Example still images from
confocal time-lapse movies to illustrate protrusion analysis (magenta) applied to migrating hWASp mutant ‘rescues’ (see supplementary material Movie 1).
Direction of the wound indicated by white arrow. (F) Quantification of rate of protrusion (i) and retraction (ii) in migrating hWASp mutant ‘rescues’. Error bars
(s.d); asterisks denote significance values of *P,0.05, **P,0.01 and ***P,0.001 by one-way ANOVA. Scale bars: 100 mm (B); 10 mm (E).
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J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
Results and Discussion
Because zebrafish larvae are translucent we are able to live image
and characterise the behaviour of WASp deficient innate immune
cells in an in vivo context. We first characterise leukocyte
behaviour in a zebrafish WASp null mutant (Fig. 1A) derived by
TILLing (Cvejic et al., 2008), which we then use as a background
line to investigate a series of human WASp alleles.
The WASp mutant has normal numbers of leukocytes but
they are defective in their ability to migrate to wounds
In humans, WASp is a haematopoietic cell restricted protein. We
show that at the mRNA and protein levels, zebrafish WASp1
expression coincides with the leukocyte marker Lysozyme C
(supplementary material Fig. S1A,B). We also confirm that
WASp1 mutant larvae have normal numbers and distribution of
neutrophils and macrophages (supplementary material Fig.
S1C,D), just as observed in most human WAS patients.
However, our wounding studies revealed reduced recruitment of
both lineages at all time points from 30 minutes to 24 hours
(Fig. 1C,D). Tracking analysis of mpx:GFP+ neutrophil migration
in WASp1 mutants indicated increased frequency of ‘pausing’ and
decreased cell velocity during migratory periods, but no significant
increase in ‘meandering’ of tracks to the wound (Fig. 1E). We
show that these alterations in migration are, at least in part, due to
inefficiency in forming and maintaining new leading pseudopods
in both paused and migrating cells, en route to wounds (Fig. 1F,G).
WASp null cells also exhibited a reduced level of uropod retraction
as they migrate towards the wound (Fig. 1H). We presume that all
of these defects in cell migration to a wound are due to WASp-
mediated influences on the cytoskeleton, but WASp proteins can
also regulate endocytosis and there is precedent for endocytosis to
dramatically influence the reading of chemotactic signals and so
we cannot rule out this possibility (Je´kely et al., 2005). There is a
second WASp orthologue in zebrafish with less sequence
homology to hWASp (Cvejic et al., 2008), but we saw no
further migration defect after knockdown of this orthologue on a
WASp mutant background (supplementary material Fig. S2).
Dissecting the function of specific human WASp mutants
in WASp null zebrafish
Having confirmed that WASp12/2 fish appear to model features
of human WASp deficiency, we wondered whether hWASp
might rescue these defects and whether we might use zebrafish larvae
as a ‘window’ through which to observe cell behaviours in a range of
hWASp lesions (Fig. 2A; supplementary material Movie 1).
Immediately obvious, and mirroring the neutropenic phenotype of
XLN patients, we found that expression of a constitutively active
form of hWASpI294T (Ancliff et al., 2006), using the neutrophil-
specific Lysozyme C (lyz) promoter in otherwise WASp mutant fish,
leads to a reduced overall number of neutrophils (Fig. 2B) in
unwounded fish. We found that transgenic expression of full-length
hWASp, again in otherwise WASp mutant fish, rescues both the
numbers of neutrophils recruited to a wound (Fig. 2C) and their
velocity and pause times en route to the wound (Fig. 2D). By contrast,
transgenic expression of WASpY291F, a phospho-dead mutant form of
hWASp (Blundell et al., 2009), provided minimal improvement in
neutrophil migration above the WASp mutant background (Fig. 2C),
and this was mirrored in our movie analysis where we saw marginally
slower migration of individual neutrophils (Fig. 2D) and
concommitantly reduced protrusion dynamics (Fig. 2E). By
contrast, when we expressed WASpH246D in neutrophils, which
cannot bind Cdc42 (Kato et al., 1999), we saw improvement in cell
motility and recruitment to a level close to that in WT larvae (Fig. 2C)
and normal protrusive outgrowth (Fig. 2E; supplementary material
Movie 1) but with marginally reduced uropod retraction (Fig. 2E).
Analysis of movies of the remaining neutrophils expressing the
constitutively active form of hWASpI294T (supplementary material
Movie 1) showed these cells to be hyperprotrusive when responding
to a wound, and with significantly increased velocity and increased
protrusion and uropod retraction rates (Fig. 2D,E); we have seen a
similar compensatory effect on migration in Drosophila macrophages
mutant in Cdc42, which exhibited defects in cell polarisation, but with
increased migratory velocity compared with WT cells (Stramer et al.,
2005). We suggest that the more muted inflammatory response to
wounds in these constitutively active WASp transgenic ‘rescues’ is
largely due to the reduced number of responding neutrophils, rather
than a retarded migratory capacity and this may reflect how the
inflammatory process is also perturbed in XLN patients.
The WASp mutant also models susceptibility to bacterial
infection, just as in human patients
Patients with WAS and XLN are prone to bacterial infections.
We observed that WASp2/2 juveniles are more prone to
opportunistic bacterial infection and subsequent death
Fig. 3. WASp mutant larvae show increased susceptibility to
death from bacterial infection. (A) Ratio of genotypes of the
offspring from WASp heterozygous in-crossed adults at 5 dpf and 3
months. Values in brackets indicate percentage drop in survival from
predicted Mendelian ratio for WASp+/2 and WASp2/2 larvae.
(B) Survival curves for WT (n544) versus mutant (n543) zebrafish
larvae injected at 52 hpf with S. aureus; control injection is with PBS,
WT (n515) mutant (n518). (C) Colony-forming unit (cfu) counts of
individual larvae injected with 1200 cfu of S. aureus at (i) 4 hours
post injection (hpi), WT (n58), mutant (n58); (ii) 10 hpi, WT
(n516), mutant (n515); (iii) 24 hpi, WT (n510), mutant (n510).
Error bars (s.d); asterisks denote significance values of *P,0.05,
**P,0.01 using Student’s t-test.
Journal of Cell Science 126 (18)4080
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Fig. 4. WASp mutant larvae show a delay in phagocytosis and defective clearance of S. aureus. (A) (i) Representative image of an infected larva. Arrowhead
indicates injection site. (ii) GFP+ clumps of phagocytosed S. aureus visible in flank region (corresponding to white rectangle in i). (iii) Further magnification
(corresponding to white square in ii) reveals a cluster of macrophages (blue) and neutrophils (magenta) with phagocytosed S. aureus (green) visible only within the
macrophage population; (iv) application of punctae analysis using Volocity enables quantification of phagocytosed (as opposed to individual, not yet engulfed) S.
aureus. (B) Representative images of bacterial punctae analysis in flanks of WT (+/+) versus mutant (2/2) larvae, revealing a delay in initial engulfment at
0.5 hpi, catch up by 2 hpi, but eventual failure to clear the phagocytosed bacteria at 24 hpi, in the mutant. (C–E) Scatter plots of (i) numbers of S. aureus punctae
and (ii) total volume of S. aureus punctae (mm3) in flanks of WT versus mutant larvae at. Successful rescue of mutant defect at (C) 0.5 hpi and (E) 24 hpi
following macrophage-specific re-expression of hWASpWT under csf1a:Gal4. (F) (i) Confocal image of PU1:GFP-positive macrophages (green) in the
haematopoietic region of 2 dpf larva 30 minutes post injection of pHrodo S. aureus Bioparticles (red). (ii) Stills from a time-lapse movie, illustrating increasing
fluorescence of a single pHrodo bioparticle following acidification in the macrophage phagosome (see supplementary material Movie 3). Arrows in single channel
series indicate phagosome as it becomes acidified. (G) Scatter plots of numbers of pHrodo S. aureus bioparticle punctae (i), and total volume of punctae (mm3)
(ii), in flanks of WT, mutant and hWASp mutant ‘rescued’ larvae at 0.5 hpi. Error bars indicate s.d.; *P,0.05, **P,0.01 and ***P,0.001 via Student’s t-test
(D) and one-way ANOVA (C,E,G). Scale bars: 200 mm (Ai); 100 mm (Aii,B); 10 mm (Aiii); 50 mm (Fi); 5 mm (Fii).
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(Fig. 3A). To investigate the degree of resistance of WASp
mutants to bacterial infection, we challenged larvae with a
systemic S. aureus infection, injected into the circulation at
52 hpf, at a dose previously shown to cause staggered larval
death over 72 hours post injection (hpi) (Prajsnar et al., 2008).
This revealed increased susceptibility to bacterial infection
in WASp mutants (Fig. 3B) and greater bacterial burden
(Fig. 3C).
In control WT fish, live imaging showed that most of the
phagocytosis of circulating microbes, is accomplished by
macrophages (Fig. 4A) (Colucci-Guyon et al., 2011) and
commences almost immediately upon loading the circulation
with S. aureus (supplementary material Movie 2). Using a
‘punctae analysis’ image quantification technique, we observed a
clear delay in phagocytosis after 30 minutes in WASp mutant
larvae, leading to a significant defect in clearance by 24 hpi
(Fig. 4B–E) which explains their increased larval death rate. We
saw no additional defect when we used morpholino knockdown
WASp2 (data not shown). We found that transgenic expression of
full-length hWASp in macrophages, using a csf1a promoter, in
otherwise WASp mutant fish, rescues phagocytic uptake of
microbes at both these timepoints to levels approaching WT
(Fig. 4C,E). We next developed a more direct assay of
phagocytosis without infection, utilising bioparticles that
fluoresce only on acidification post phagocytic uptake (Fig. 4F;
supplementary material Movie 3) (Brubaker et al., 2013). We
used this assay to test the capacity of two of the hWASp mutant
alleles investigated in our neutrophil motility ‘rescue’, but this
time using the PU.1 promoter to drive them in macrophages.
Our data here suggest a significantly increased ‘rescue’
of phagocytosis in cells expressing WASpY291F, the phospho-
dead mutant form of hWASp, above the WASp null background
(Fig. 4G), whereas Cdc42 signalling seems absolutely essential
because when we expressed WASpH246D, which cannot bind
Cdc42, in otherwise WASp null macrophages, we saw no
improvement in particle uptake (Fig. 4G).
This disassociation of Cdc42 activation and phosphorylation
status of WASp has been reported previously and there is
precedent from in vitro studies that WASp phosphorylation can
occur independently of Cdc42 binding in cell migration and other
WASp-dependent functions, whereas Cdc42 is essential for
WASp-regulated phagocytosis (Badour et al., 2004; Cory et al.,
2002; Park and Cox, 2009).
Overall, our data establish a model for investigating WASp
function in vivo and reveal the potential for live imaging the effects
of various human WAS disease-related mutations using zebrafish
larvae as host ‘windows’ for observing immune cell behaviours.
To our knowledge, this is the first occasion where a range of
human disease alleles have been transgenically expressed and
comparatively live imaged using zebrafish larvae in this way.
Materials and Methods
Zebrafish lines and maintenance
Adult zebrafish were maintained in standard conditions; breeding and genotyping
were carried out according to standard protocols (Westerfield, 2000). Embryos
were maintained at 28 C˚ in 0.36Danieu’s solution. For strains generated and used
in this study, see supplementary material Table S1.
Leukocyte staining
Sudan Black staining was used to reveal neutrophils (Cvejic et al., 2008), and a
pan-leukocytic antibody, L-Plastin was used to stain for all leukocytes as
previously described (Redd et al., 2006).
Tail-fin wounding
Mechanical wounding was performed as previously described (Cvejic et al., 2008);
in brief, 3 dpf larvae were anaesthetised and their ventral tail fin wounded using a
tungsten needle (Fig. 1B).
Infection protocol
1 nl of 1.26109 cfu ml21 GFP-expressing S. aureus or 2 mg/ml pHrodo-S. aureus
BioPaticles (Invitrogen), resuspended in PBS, were microinjected into the Duct of
Cuvier of anaesthetised 52 dpf larvae. For live S. aureus injections, WT and
mutant larvae were monitored over the course of 3 days until 5 dpf. Dead larvae
were counted and removed at 24 hour post injection (hpi), 48 hpi and 72 hpi. To
measure bacterial burden, individual 4 hpi, 10 hpi and 24 hpi larvae were
processed for cfu analysis using an adaption of a previous protocol (Prajsnar et al.,
2008), whereby each larva was first lysed in 400 ul 0.5% Triton X-100 and plated
on a 90 mm LB agar plate.
In vivo live imaging
Live imaging was performed according to our previously published protocol.
(Cvejic et al., 2008). A widefield Leica DMIRB inverted microscope was used to
take movies for tracking studies and an Ultraview Spinning Disk Confocal imaging
system with a 636 glycerol lens was used for protrusion/retraction analysis.
Image acquisition and quantification
Quantification of phagocytosed bacterial/BioParticle burden was performed on
images of fixed, infected larval flanks, captured on a confocal microscope using
206 lens. Images were processed using Volocity (Improvision) software with
GFP+/RFP+ bacterial clumps identified using s.d. intensity (12,s.d.,170).
Parameters were refined to isolate large phagosomes over individual bacterium/
BioParticles by setting a size threshold .5 mm. The manual tracking function of
Volocity 5.0 (Improvision) was used to track neutrophil migration. Quantification
of new protrusive areas and uropod retraction was performed using NIH ImageJ
1.42q software. On conversion of the movie to 8-bit greyscale, the movie was
duplicated. In the duplicate copy the first frame was removed and a blank frame
added at the end. Using the ‘Image calculator’ function the duplicate movie was
subtracted from the original to reveal the new protrusive area; the reverse process
was applied for retraction analysis. Following inversion of the image, the
protrusive/retracted areas (mm2) could be calculated using the function ‘Analyse
particles’. For paused cell movie analysis, the cell was divided in half, front and
back, using the location of wound as a reference point, before calculation of areas
were performed.
Construction of vectors for generating transgenic fish for each hWASp
mutant
cDNAs for each eGFP-WASp mutant were cloned in frame between (NheI, ClaI)
sites of the transgenic parental vector pBH-UASmsc, which contains the Tol2
sequence and a mlc promoter driven mCherry as transgene screen marker (kindly
provided by Michael Nonet, Washington University). All the constructs were
sequenced to verify their coding sequences.
Establishing zebafish transgenic strains containing UAS-WASp mutants
A Tol2 transposase mediated transgenic strategy (Kawakami et al., 2000) was used
to generate UAS-WASp mutant strains following the established protocol
(Balciunas et al., 2006). F0 embryos were grown to adulthood and then either in
crossed or crossed to WASp2/2; their offspring were screened using fluorescent red
heart as transgenic marker. F1 embryos with red hearts were grown up to establish
Tg(BH-UAS-mcs-hWASp-eGFP); Tg(BH-UAS-mcs-hWASpA134T-eGFP); Tg(BH-
UAS-mcs-hWASpH246D-eGFP); Tg(BH-UAS-mcs-hWASpY291F-eGFP); Tg(BH-
UAS-mcs-hWASpI294T-eGFP), that were used in this study and crossed as
appropriate.
For each of our rescue experiments we have tested, as far as is possible, whether
physiologically relevant levels of transgenic hWASp mRNAs/proteins are being
expressed, by semi-quantitive RT-PCR (bands of similar intensity in WT and
rescued larvae, supplementary material Fig. S1E), and immunostaining (data not
shown), although absolute comparisons are not possible because we use different
antibodies to image the zebrafish and human WASp proteins.
Production of WASp1 antibody
Zebrafish WASp1 cDNA fragment (1–699) was cloned into pGEX in frame.
pGEX-zfWASp (1–699) was used to express a zfWASp–GST fusion protein in E.
coli BL21 following the standard manufacturer’s protocol. zfWASp was affinity
purified using a Gluthathione Sepharose 4B column, and the final protein was sent
to David’s Biotechnologie (Germany) for production of rabbit polyclonal antibody.
The specificity of the received zfWASp1 anti-serum was confirmed by ELISA.
WASp2 morpholino
Splice blocking (CAGAGACTGCAGACAAAAACACAAA) and translation
blocking (CTTTCCCCTTCCGGCTCGCCTCAT) morpholinos were designed
Journal of Cell Science 126 (18)4082
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against WASp2 (Cvejic et al., 2008) and injected at concentration of 2 mg/ml and
2.5 mg/ml, respectively.
In situ probes
zfWASp1 cDNA was cloned into pTOPOCRII (Invitrogen). NotI enzyme was used
to linearise the vector and SP6 was used to transcribe DIG labeled RNA probe for
zfWASp1 using a Clontech DIG RNA labelling mix and following the
manufacturer’s guidelines.
RT-PCR and qPCR
Ten larvae from each genotype were lysed in 1 ml TRIzol (Invitrogen) and RNA
were purified following the manufacturer’s user guide. First strand cDNA were
synthesised using SuperScript III Reverse Transcriptase system (Invitrogen),
following the user manual and resulting cDNAs were used for subsequent PCR
assays. qPCR was performed using an Opticon2 machine and SYBR green
reagents, according to the manufacturer’s instructions. Primer sequences used were
as follows (59–39): zfWASp1 forward (CAGTTATACATGGCCCTTCCTC),
reverse (CACTTTCGCTTCCATAATGTCA); L-Plastin forward (CCTGACGGA-
TGAAAAGAAGC), reverse (ATCACCATCTTGGGCTTCAC); hWASp forward
(TACTTCATCCGCCTTTACGG), reverse (GTCATCTCCAGCGAAGGTGT);
Efa (CTGGTTCAAGGGATGGAAGA), reverse (GAGACTCGTGGTGCAT-
CTCA). For all the reactions, annealing temperature was 60 C˚, with elongation
for 30 seconds, for 40 cycles.
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